Calidi Biotherapeutics
CLDI · NYSE American
$0.77−$0.0134 (−1.71%)TodayMarket closed ·
Prev close $0.7834
Who owns CLDI
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 0.2% of CLDI’s shares.
- Leftwich (Scott)0.0%
- Geode Capital Management, L.L.C.0.0%
- Schoeneck (James A)0.0%
- Hightower Advisors, LLC0.0%
- Next 6 largest institutions0.1%
- All other shareholders99.8%
| Holder | Shares | % of shares |
|---|---|---|
| Leftwich (Scott) | 9.16K | 0.05% |
| Geode Capital Management, L.L.C. | 7.16K | 0.04% |
| Schoeneck (James A) | 5.28K | 0.03% |
| Hightower Advisors, LLC | 5.22K | 0.03% |
| Jane Street Capital, L.L.C. | 3.39K | 0.02% |
| Jamir Trust | 3.17K | 0.02% |
| Independent Advisor Alliance, LLC | 2.81K | 0.01% |
| RS Crum INC | 2.70K | 0.01% |
| Arax Advisory Partners | 2.33K | 0.01% |
| Private Advisor Group LLC | 1.88K | 0.01% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Fidelity Extended Market Index Fund | 6.33K | 0.03% |
| Vanguard Extended Market Index Fund | 1.59K | 0.01% |
| Fidelity Total Market Index Fund | 321 | 0.00% |
| Fidelity Series Total Market Index Fund | 290 | 0.00% |
Insider trades
Form 4 filings by officers, directors and large holders
Insiders made no open-market buys or sales of CLDI in the last 6 months.
| Insider | Type | Shares | Value |
|---|---|---|---|
| Peoples George | Award | 4.00K | — |
| Leftwich Scott | Award | 4.00K | — |
| Fernandez Santidrian Antonio | Award | 16.00K | — |
| Sanders Corazon (Corsee) D. | Award | 6.00K | — |
| Stewart Alan R. | Award | 4.00K | — |
| Jackson Andrew C. | Award | 14.00K | — |
| Schoeneck James A | Award | 5.00K | — |
| Poma Eric E | Award | 32.00K | — |
Short interest
Settled Sep 30, 2026
- Shares short
- 233.29K
- Days to cover
- 1.00
- % of shares outstanding
- 1.21%
- Average daily volume
- 380.10K
- Change since last report
- +2.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.